BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30635636)

  • 1. Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.
    Hohtari H; Brück O; Blom S; Turkki R; Sinisalo M; Kovanen PE; Kallioniemi O; Pellinen T; Porkka K; Mustjoki S
    Leukemia; 2019 Jul; 33(7):1570-1582. PubMed ID: 30635636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.
    Brück O; Blom S; Dufva O; Turkki R; Chheda H; Ribeiro A; Kovanen P; Aittokallio T; Koskenvesa P; Kallioniemi O; Porkka K; Pellinen T; Mustjoki S
    Leukemia; 2018 Jul; 32(7):1643-1656. PubMed ID: 29925907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia.
    Chen SY; Yang X; Feng WL; Liao JF; Wang LN; Feng L; Lin YM; Ren Q; Zheng GG
    J Immunol; 2015 Mar; 194(6):2919-29. PubMed ID: 25662994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-associated alterations in marrow T cells in pediatric leukemia.
    Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D; Castellino S; Kemp ML; Qiu P; Dhodapkar MV; Dhodapkar KM
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32692727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRTAM
    Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
    J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
    Feuerer M; Rocha M; Bai L; Umansky V; Solomayer EF; Bastert G; Diel IJ; Schirrmacher V
    Int J Cancer; 2001 Apr; 92(1):96-105. PubMed ID: 11279612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
    J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
    Ruggeri A; Labopin M; Bacigalupo A; Gülbas Z; Koc Y; Blaise D; Bruno B; Irrera G; Tischer J; Diez-Martin JL; Castagna L; Ciceri F; Mohty M; Nagler A
    Cancer; 2018 Apr; 124(7):1428-1437. PubMed ID: 29360162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang YT; Kong Y; Song Y; Han W; Zhang YY; Zhang XH; Chang YJ; Jiang ZF; Huang XJ
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1376-1382. PubMed ID: 27131864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
    Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M
    Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
    Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
    Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
    Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
    J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.
    Jiang H; Li C; Yin P; Guo T; Liu L; Xia L; Wu Y; Zhou F; Ai L; Shi W; Lu X; Wang H; Tang L; Wei Q; Deng J; Jin R; Xiong W; Dong J; Mei H; Hu Y
    Am J Hematol; 2019 Oct; 94(10):1113-1122. PubMed ID: 31321805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
    Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
    Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Epstein-Barr virus-related disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation is associated with impaired early recovery of T and B lymphocytes.
    Liu J; Yan C; Zhang C; Xu L; Liu Y; Huang X
    Clin Transplant; 2015 Oct; 29(10):904-10. PubMed ID: 26185947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.